# Clinical Trial to Compare Pharmacokinetics After Administration of ATB-101 or Co-administration of ATB-1011 and ATB-1012

> **NCT05017987** · PHASE1 · COMPLETED · sponsor: **Autotelicbio** · enrollment: 36 (actual)

## Conditions studied

- Healthy Adult Volunteers

## Interventions

- **DRUG:** ATB-101, ATB-1011, ATB-1012

## Key facts

- **NCT ID:** NCT05017987
- **Lead sponsor:** Autotelicbio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-19
- **Primary completion:** 2021-07-12
- **Final completion:** 2021-07-12
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2024-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05017987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05017987, "Clinical Trial to Compare Pharmacokinetics After Administration of ATB-101 or Co-administration of ATB-1011 and ATB-1012". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05017987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*